-
Innovation Ranking
NewInnovation Ranking – AMAG Austria Metall AG
AMAG Austria Metall AG (AMAG) is a producer and supplier of primary aluminium and aluminium semi-finished products. It offers aluminium rolled products such as aluminium plates, strips and sheets. The company produces aluminium cast alloys in the form of horizontal continual casting ingots, two-piece ingots, sows and liquid aluminium. It offers customized cathode elements for tread plate, zinc smelters, brazing materials, and high strength alloys. Its products find applications in aviation, construction, electronics, automotive, consumer goods, sports equipment and packaging...
-
Product Insights
Amager Power Station
Amager Power Station is a biopower project located in Capital Region of Denmark, Denmark. The project is owned and developed by HOFOR Energiproduktion AS. The project came online in 2010. Empower your strategies with our Amager Power Station report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Product Insights
Amager Bakke WTE Plant 1
Amager Bakke WTE Plant 1 is a biopower project located in Capital Region of Denmark, Denmark. The project is owned and developed by Amager Ressource Center. The project came online in 1990. Empower your strategies with our Amager Bakke WTE Plant 1 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
Amager Bakke Waste-To-Energy plant
Amager Bakke Waste-To-Energy plant is a biopower project located in Capital Region of Denmark, Denmark. The project is owned by Amager Ressource Center. The project came online in 2017. Empower your strategies with our Amager Bakke Waste-To-Energy plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Company Profile
AMAG Pharmaceuticals Inc – Company Profile
AMAG Pharmaceuticals Inc (AMAG) is a pharmaceutical company focused on the development and commercialization of specialty pharmaceutical products in therapeutic areas like maternal, women's health, anemia management, and hematology. Its product portfolio includes Makena an auto-injector device, and Feraheme for intravenous. The company is developing two product pipelines; Ciraparantag is in the Phase 2b trial of healthy volunteers and AMAG-423 is in the phase 2b/3a trial. The company offers its products through a direct sales force and a network of...
Add to Basket -
Company Profile
AMAG Austria Metall AG – Company Profile
AMAG Austria Metall AG (AMAG) is a producer and supplier of primary aluminium and aluminium semi-finished products. It offers aluminium rolled products such as aluminium plates, strips and sheets. The company produces aluminium cast alloys in the form of horizontal continual casting ingots, two-piece ingots, sows and liquid aluminium. It offers customized cathode elements for tread plate, zinc smelters, brazing materials, and high strength alloys. Its products find applications in aviation, construction, electronics, automotive, consumer goods, sports equipment and packaging...
Add to Basket -
Company Profile
Antares Pharma Inc – Company Profile
Antares Pharma Inc (Antares Pharma), a subsidiary of Halozyme Therapeutics Inc, is a specialty pharmaceutical company engaged in the development, manufacturing, and commercialization of pharmaceutical products and technologies. The company’s portfolio encompasses around novel therapeutic products for therapy areas related to polyarticular juvenile idiopathic arthritis, severe rheumatoid arthritis, severe recalcitrant psoriasis, migraine and cluster headache. It also develops products to reduce the risk of preterm birth in pregnant women. It caters its subcutaneous injection technology platforms to both generic and...
Add to Basket -
Product Insights
Antares Pharma Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Antares Pharma Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company engaged in the development, manufacturing, and commercialization of pharmaceutical products and technologies. The company’s portfolio encompasses around novel therapeutic products for therapy areas related to polyarticular juvenile idiopathic arthritis, severe rheumatoid arthritis, severe recalcitrant psoriasis, migraine and cluster headache. It also develops products to reduce the risk of preterm...
-
Product Insights
Female Hypoactive Sexual Desire Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Female Hypoactive Sexual Desire Disorder pipeline market report provides a comprehensive overview of the therapeutics under development for Female Hypoactive Sexual Desire Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic...
-
Sector Analysis
Chronic Kidney Disease Anemia – Global Drug Forecast and Market Analysis to 2029
Anemia is a common complication of chronic kidney disease (CKD) that is most frequently attributed to insufficient synthesis of erythropoietin (EPO) due to kidney damage. CKD anemia is highly prevalent among CKD patients and its prevalence increases as CKD progresses, affecting more than half of patients in stage V. Over the last 20 years, the CKD anemia market has grown exponentially. Treatment of CKD anemia was significantly improved following the introduction of recombinant human EPO (rHuEPO), and ESAs have dominated...